↓ Skip to main content

PTENgenomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity

Overview of attention for article published in BMC Cancer, November 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PTENgenomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
Published in
BMC Cancer, November 2012
DOI 10.1186/1471-2407-12-543
Pubmed ID
Authors

Khalil Choucair, Joshua Ejdelman, Fadi Brimo, Armen Aprikian, Simone Chevalier, Jacques Lapointe

Abstract

Prostate cancer (PCa), a leading cause of cancer death in North American men, displays a broad range of clinical outcome from relatively indolent to lethal metastatic disease. Several genomic alterations have been identified in PCa which may serve as predictors of progression. PTEN, (10q23.3), is a negative regulator of the phosphatidylinositol 3-kinase (PIK3)/AKT survival pathway and a tumor suppressor frequently deleted in PCa. The androgen receptor (AR) signalling pathway is known to play an important role in PCa and its blockade constitutes a commonly used treatment modality. In this study, we assessed the deletion status of PTEN along with AR expression levels in 43 primary PCa specimens with clinical follow-up.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Canada 1 2%
Brazil 1 2%
Unknown 54 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 26%
Researcher 10 18%
Student > Bachelor 9 16%
Professor 3 5%
Student > Postgraduate 3 5%
Other 11 19%
Unknown 6 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 18 32%
Medicine and Dentistry 14 25%
Biochemistry, Genetics and Molecular Biology 9 16%
Nursing and Health Professions 1 2%
Unspecified 1 2%
Other 2 4%
Unknown 12 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2012.
All research outputs
#18,321,703
of 22,687,320 outputs
Outputs from BMC Cancer
#5,415
of 8,249 outputs
Outputs of similar age
#214,138
of 275,925 outputs
Outputs of similar age from BMC Cancer
#69
of 106 outputs
Altmetric has tracked 22,687,320 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,249 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,925 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.